JAVMA news
All hydrocodone products now schedule II drugs
The Drug Enforcement Administration has scheduled all hydrocodone-containing products as schedule II drugs
JAVMA news
FDA’s Dunham delves into drug issues
Dr. Bernadette Dunham, director of the Food and Drug Administration’s Center for Veterinary Medicine, recently fielded questions about drug issues and…
JAVMA news
Tramadol becomes controlled substance
The Drug Enforcement Administration has designated tramadol as a controlled substance
Your Pet's Medications
Provides basic information for pet owners about pet medications and their safe use.
JAVMA news
AVMF chair service-oriented
Dr. John R. Brooks of Kingsville, Maryland, is now chair of the American Veterinary Medical Foundation’s board of directors
JAVMA news
For Cohn, relevance of AVMA and profession is front-and-center
Incoming president shares his concerns and hopes
JAVMA news
AVMA also planning member-centered changes
Dr. Ron DeHaven, AVMA CEO, said the AVMA plans to implement its branding efforts starting this summer.
JAVMA news
Board makes appointments
The AVMA Executive Board made the following appointments during its April meeting.
JAVMA news
Antitrust caution clashes with workforce concerns
According to the Federal Trade Commission, it’s not for the AVMA to decide how many veterinarians are in the marketplace.
JAVMA news
A practitioner, through and through
Dr. Clark K. Fobian spoke about how serving as the Association’s top officer has shaped his view of the AVMA and the veterinary profession
JAVMA news
Substitution errors
Ten percent of veterinarians responding to recent polls said they have had patients harmed when outside pharmacies made substitutions in filling…
JAVMA news
Staying Afloat
Pet health insurance has grown more popular, although its use is still not widespread.
JAVMA news
AVMA presidential candidates, in their own words
This July in Denver, the AVMA House of Delegates will elect either Dr. Larry G. Dee or Dr. Joseph H. Kinnarney as next in line for the AVMA presidency